{
    "root": "f9953d60-1a19-a3c1-e053-6394a90a5b42",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Losartan Potassium",
    "value": "20230417",
    "ingredients": [
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED",
            "code": "2165RE0K14"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "LOSARTAN POTASSIUM",
            "code": "3ST302B24A"
        }
    ],
    "indications": "Losartan potassium tablet is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. ( 1.2 ) Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. ( 1.3 )",
    "contraindications": "Hypertension Usual adult dose: 50 mg once daily. ( 2.1 ) Usual pediatric starting dose: 0.7 mg per kg once daily (up to 50 mg). ( 2.1 ) Hypertensive Patients with Left Ventricular Hypertrophy Usual starting dose: 50 mg once daily. ( 2.2 ) Add hydrochlorothiazide 12.5 mg and/or increase losartan potassium tablets to 100 mg followed by an increase to hydrochlorothiazide 25 mg if further blood pressure response is needed. ( 2.2 , 14.2 ) Nephropathy in Type 2 Diabetic Patients Usual dose: 50 mg once daily. ( 2.3 ) Increase dose to 100 mg once daily if further blood pressure response is needed. ( 2.3 )",
    "warningsAndPrecautions": "Losartan potassium tablets, USP are available as follows:\n                  \n                     \n                     Losartan potassium tablets USP, 25 mg\n                     \nWhite to off white, film coated, oval shaped tablets debossed with \"I16\" on one side and plain on other side.\n \n                  Bottles of 30        NDC 62207-741-54\n                  Bottles of 1000    NDC 62207-741-49\n                  \n                     \n                     Losartan potassium tablets USP, 50 mg\n                     \nWhite to off white, film coated, oval shaped scored tablets debossed with \"I\" and \"17\" on either side of the score line on one side and plain on other side.\n \n                  Bottles of 30        NDC 62207-742-54\n                  Bottles of 1000    NDC 62207-742-49\n                  \n                     \n                     Losartan potassium tablets USP, 100 mg\n                     \nWhite to off white, film coated, oval shaped tablets debossed with \"I18\" on one side and plain on other side.\n \n                  \n                  \n                  Bottles of 30        NDC 62207-743-54\n                  Bottles of 1000    NDC 62207-743-49\n                  \n                     \nStore at 25째C (77째F); excursions permitted to 15 to 30째C (59 to 86째F) [see USP Controlled Room Temperature]. Keep container tightly closed. Protect from light.",
    "adverseReactions": "Losartan potassium tablets, are contraindicated:\n                  \n                     In patients who are hypersensitive to any component of this product.\n                     For coadministration with aliskiren in patients with diabetes."
}